Aprea Therapeutics, Inc. (APRE)

0.9499 +0.14 (+17.97%) USD  |  NASDAQ  |  Aug 25, 16:00
1.00 +0.05 (+5.27%) After-Hours: 04:52
More

Aprea Therapeutics EPS Estimates for Next Quarter

EPS Estimates for Next Quarter Chart

View EPS Estimates for Next Quarter for APRE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Estimates for Next Quarter Chart
Start Trial

Historical EPS Estimates for Next Quarter Data

View and export this data back to 2024. Start Trial.
Date Value
August 13, 2026 --
August 12, 2026 --
August 10, 2026 --
June 01, 2026 --
May 15, 2026 --
May 13, 2026 --
May 07, 2026 --
Date Value
March 31, 2026 --
March 16, 2026 --
August 12, 2025 --
May 14, 2025 --
August 12, 2024 --
May 14, 2024 --
March 26, 2024 --

Earnings Per Share Estimates Definition

This is the earnings consensus estimate for a given period of time, according to analysts polled by Standard & Poor's.

Read full definition.

EPS Estimates for Next Quarter Range, Past 5 Years

View EPS Estimates for Next Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Estimates for Next Quarter Benchmarks

View EPS Estimates for Next Quarter Benchmarks
Start Trial
Zymeworks, Inc. Upgrade
Rhythm Pharmaceuticals, Inc. Upgrade
Onconetix, Inc. --
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade

EPS Estimates for Next Quarter Related Metrics

Revenue Estimates for Current Quarter Upgrade
Revenue Estimates for Next Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade